Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK-4208 (Tern-701) in Chronic Myeloid Leukemia
NCT06163430Phase 2Recruiting
- Sponsor
- Merck & Co.
- Start
- Mar 2024
- Primary completion
- Nov 2029
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 2 trial of TERN-701 in chronic myeloid leukemia (CML), sponsored by Merck & Co.. Started Mar 2024; status: recruiting.
02
Drugs
TERN-701
03
Conditions
chronic myeloid leukemia (CML)
Beyond the preview
Go deeper on NCT06163430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06163430.